S&P 500   3,366.58 (-0.40%)
DOW   29,188.39 (-0.71%)
QQQ   234.36 (-0.12%)
AAPL   317.80 (-2.20%)
FB   217.30 (+1.46%)
MSFT   186.75 (+0.76%)
GOOGL   1,518.30 (-0.03%)
AMZN   2,158.95 (+1.13%)
CGC   22.63 (+2.26%)
NVDA   292.61 (+0.97%)
BABA   219.16 (-0.21%)
MU   57.69 (-1.38%)
GE   12.72 (-0.86%)
TSLA   850.29 (+6.28%)
AMD   57.53 (+4.01%)
T   38.23 (-0.05%)
ACB   1.63 (+3.16%)
F   8.03 (-0.86%)
NFLX   388.06 (+2.01%)
PRI   135.65 (-0.87%)
BAC   34.23 (-1.78%)
DIS   138.48 (-0.76%)
GILD   66.86 (-1.04%)
S&P 500   3,366.58 (-0.40%)
DOW   29,188.39 (-0.71%)
QQQ   234.36 (-0.12%)
AAPL   317.80 (-2.20%)
FB   217.30 (+1.46%)
MSFT   186.75 (+0.76%)
GOOGL   1,518.30 (-0.03%)
AMZN   2,158.95 (+1.13%)
CGC   22.63 (+2.26%)
NVDA   292.61 (+0.97%)
BABA   219.16 (-0.21%)
MU   57.69 (-1.38%)
GE   12.72 (-0.86%)
TSLA   850.29 (+6.28%)
AMD   57.53 (+4.01%)
T   38.23 (-0.05%)
ACB   1.63 (+3.16%)
F   8.03 (-0.86%)
NFLX   388.06 (+2.01%)
PRI   135.65 (-0.87%)
BAC   34.23 (-1.78%)
DIS   138.48 (-0.76%)
GILD   66.86 (-1.04%)
S&P 500   3,366.58 (-0.40%)
DOW   29,188.39 (-0.71%)
QQQ   234.36 (-0.12%)
AAPL   317.80 (-2.20%)
FB   217.30 (+1.46%)
MSFT   186.75 (+0.76%)
GOOGL   1,518.30 (-0.03%)
AMZN   2,158.95 (+1.13%)
CGC   22.63 (+2.26%)
NVDA   292.61 (+0.97%)
BABA   219.16 (-0.21%)
MU   57.69 (-1.38%)
GE   12.72 (-0.86%)
TSLA   850.29 (+6.28%)
AMD   57.53 (+4.01%)
T   38.23 (-0.05%)
ACB   1.63 (+3.16%)
F   8.03 (-0.86%)
NFLX   388.06 (+2.01%)
PRI   135.65 (-0.87%)
BAC   34.23 (-1.78%)
DIS   138.48 (-0.76%)
GILD   66.86 (-1.04%)
S&P 500   3,366.58 (-0.40%)
DOW   29,188.39 (-0.71%)
QQQ   234.36 (-0.12%)
AAPL   317.80 (-2.20%)
FB   217.30 (+1.46%)
MSFT   186.75 (+0.76%)
GOOGL   1,518.30 (-0.03%)
AMZN   2,158.95 (+1.13%)
CGC   22.63 (+2.26%)
NVDA   292.61 (+0.97%)
BABA   219.16 (-0.21%)
MU   57.69 (-1.38%)
GE   12.72 (-0.86%)
TSLA   850.29 (+6.28%)
AMD   57.53 (+4.01%)
T   38.23 (-0.05%)
ACB   1.63 (+3.16%)
F   8.03 (-0.86%)
NFLX   388.06 (+2.01%)
PRI   135.65 (-0.87%)
BAC   34.23 (-1.78%)
DIS   138.48 (-0.76%)
GILD   66.86 (-1.04%)
Log in

ANI Pharmaceuticals SEC Filings & 10K Form (NASDAQ:ANIP)

$64.97
-0.69 (-1.05 %)
(As of 02/18/2020 01:50 PM ET)
Today's Range
$64.51
Now: $64.97
$65.70
50-Day Range
$53.67
MA: $61.46
$67.14
52-Week Range
$53.54
Now: $64.97
$86.96
Volume1,723 shs
Average Volume61,256 shs
Market Capitalization$785.49 million
P/E Ratio48.13
Dividend YieldN/A
Beta1.98

SEC Filings

ANI Pharmaceuticals (NASDAQ:ANIP) SEC Filings

DateFilerForm TypeView
01/22/2020
4:00 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
7:30 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2019
3:35 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2019
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
7:33 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
7:31 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2019
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
1:13 PM
ANI Pharmaceuticals (Issuer)
Brown Robert E. JR (Reporting)
Meridian Venture Partners II GP, L.P. (Reporting)
MERIDIAN VENTURE PARTNERS II LP (Reporting)
Meridian Venture Partners II, Co. (Reporting)
Form 4/A
08/21/2019
5:11 PM
ANI Pharmaceuticals (Issuer)
Brown Robert E. JR (Reporting)
Meridian Venture Partners II GP, L.P. (Reporting)
MERIDIAN VENTURE PARTNERS II LP (Reporting)
Meridian Venture Partners II, Co. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
4:38 PM
ANI Pharmaceuticals (Issuer)
Brown Robert E. JR (Reporting)
Meridian Venture Partners II GP, L.P. (Reporting)
MERIDIAN VENTURE PARTNERS II LP (Reporting)
Meridian Venture Partners II, Co. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
5:07 PM
ANI Pharmaceuticals (Issuer)
Brown Robert E. JR (Reporting)
Meridian Venture Partners II GP, L.P. (Reporting)
MERIDIAN VENTURE PARTNERS II LP (Reporting)
Meridian Venture Partners II, Co. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
7:31 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2019
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
9:43 AM
ANI Pharmaceuticals (Filer)
Form CT ORDER
06/12/2019
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2019
3:00 PM
ANI Pharmaceuticals (Issuer)
NASH DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:30 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
4:16 PM
ANI Pharmaceuticals (Issuer)
PRZYBYL ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:32 PM
ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:32 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2019
3:01 PM
ANI Pharmaceuticals (Issuer)
Schrepfer Robert W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
7:31 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
6:30 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
3:34 PM
ANI Pharmaceuticals (Issuer)
Schrepfer Robert W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2019
3:33 PM
ANI Pharmaceuticals (Issuer)
PRZYBYL ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2019
3:33 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
3:45 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
3:43 PM
ANI Pharmaceuticals (Issuer)
Schrepfer Robert W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
3:42 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
3:41 PM
ANI Pharmaceuticals (Issuer)
PRZYBYL ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2019
3:17 PM
ANI Pharmaceuticals (Filer)
Form DEFA14A
04/04/2019
3:15 PM
ANI Pharmaceuticals (Filer)
Form DEF 14A
04/02/2019
3:48 PM
ANI Pharmaceuticals (Issuer)
Schrepfer Robert W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:46 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:45 PM
ANI Pharmaceuticals (Issuer)
PRZYBYL ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:42 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:02 PM
ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:02 PM
ANI Pharmaceuticals (Issuer)
NASH DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:02 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:01 PM
ANI Pharmaceuticals (Issuer)
PRZYBYL ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:01 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:01 PM
ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:01 PM
ANI Pharmaceuticals (Issuer)
Brown Robert E. JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:00 PM
ANI Pharmaceuticals (Issuer)
Schrepfer Robert W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:00 PM
ANI Pharmaceuticals (Issuer)
Penn Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
3:07 PM
ANI Pharmaceuticals (Issuer)
PRZYBYL ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
2:56 PM
ANI Pharmaceuticals (Filer)
Form CT ORDER
03/15/2019
3:31 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
5:02 AM
ANI Pharmaceuticals (Issuer)
Schrepfer Robert W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2019
3:57 PM
ANI Pharmaceuticals (Filer)
Form CT ORDER
02/22/2019
3:38 PM
ANI Pharmaceuticals (Filer)
Form CT ORDER
02/20/2019
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2019
3:45 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2019
12:46 PM
ANI Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/02/2019
4:24 PM
ANI Pharmaceuticals (Issuer)
PRZYBYL ARTHUR (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
12/27/2018
3:35 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
3:17 PM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2018
3:30 PM
ANI Pharmaceuticals (Issuer)
Schrepfer Robert W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2018
3:36 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
3:17 PM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2018
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2018
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2018
3:02 PM
ANI Pharmaceuticals (Issuer)
PRZYBYL ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
3:02 PM
ANI Pharmaceuticals (Issuer)
Schrepfer Robert W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
3:01 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
3:01 PM
ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/24/2018
3:00 PM
ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/24/2018
3:00 PM
ANI Pharmaceuticals (Issuer)
NASH DAVID (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/22/2018
7:30 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2018
3:22 PM
ANI Pharmaceuticals (Issuer)
MARSHBANKS TRACY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2018
7:30 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2018
5:30 PM
ANI Pharmaceuticals (Issuer)
MARSHBANKS TRACY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2018
3:31 PM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2018
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2018
7:35 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2018
5:33 PM
ANI Pharmaceuticals (Issuer)
MARSHBANKS TRACY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2018
3:37 PM
ANI Pharmaceuticals (Issuer)
Schrepfer Robert W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2018
3:36 PM
ANI Pharmaceuticals (Issuer)
PRZYBYL ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2018
3:34 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2018
4:26 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2018
4:25 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2018
4:23 PM
ANI Pharmaceuticals (Issuer)
PRZYBYL ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2018
4:21 PM
ANI Pharmaceuticals (Issuer)
Schrepfer Robert W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2018
3:14 PM
ANI Pharmaceuticals (Filer)
Form DEF 14A
04/05/2018
10:54 AM
ANI Pharmaceuticals (Filer)
Form CT ORDER
04/03/2018
4:21 PM
ANI Pharmaceuticals (Issuer)
Schrepfer Robert W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2018
4:14 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2018
4:00 PM
ANI Pharmaceuticals (Issuer)
HOLUBOW FRED (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2018
4:54 PM
ANI Pharmaceuticals (Issuer)
MARSHBANKS TRACY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2018
6:02 PM
ANI Pharmaceuticals (Issuer)
PRZYBYL ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2018
4:33 PM
ANI Pharmaceuticals (Issuer)
RAYNOR DANIEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2018
6:26 PM
ANI Pharmaceuticals (Issuer)
MARSHBANKS TRACY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2018
4:00 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2018
7:30 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: Golden Cross

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel